|

货币单位:美元(USD)

艾尔建制药公司

Allergan UC (agn)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Robert A. Michael	Robert A. Michael currently works at AbbVie, Inc., as Chairman & Chief Executive Officer from 2025, Fremont Holding LLC, as Chief Executive Officer, Tobira Therapeutics, Inc., as Chief Executive Officer, Allergan UC, as President & Vice Chairman from 2020, AbbVie Biotherapeutics Ltd., as Director from 2019, and AbbVie Ltd. (United Kingdom), as President & Chief Operating Officer from 2022. Mr. Michael also formerly worked at Allergan GI Corp., as President & Director and Abbott Laboratories, as Division Controller-Nutrition Supply Chain from 1993 to 2012. Mr. Michael received his undergraduate degree from Kelley School of Business and Masters Business Admin degree from UCLA Anderson School of Management.

Robert A. Michael

Robert A. Michael currently works at AbbVie, Inc., as Chairman & Chief Executive Officer from 2025, Fremont Holding LLC, as Chief Executive Officer, Tobira Therapeutics, Inc., as Chief Executive Officer, Allergan UC, as President & Vice Chairman from 2020, AbbVie Biotherapeutics Ltd., as Director from 2019, and AbbVie Ltd. (United Kingdom), as President & Chief Operating Officer from 2022. Mr. Michael also formerly worked at Allergan GI Corp., as President & Director and Abbott Laboratories, as Division Controller-Nutrition Supply Chain from 1993 to 2012. Mr. Michael received his undergraduate degree from Kelley School of Business and Masters Business Admin degree from UCLA Anderson School of Management.